Aimeike said on an interactive platform on July 15 that the company's botulinum toxin products have not yet been marketed and that the company's marketing and sales team is actively preparing for the market in accordance with the established plan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.